Expertise in
8
conditions

Frederic Goffin

CHU Liège
Liege, WAL, BE 
Expertise in
8
conditions
CHU Liège
Liege, WAL, BE 

Overview

Frederic Goffin practices practicing medicine in Liege, Belgium.

Mr. Goffin is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Gestational Trophoblastic Disease, Cervical Cancer, Endometrial Cancer, Hysterectomy, and Lymphadenectomy.

He is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

CHU Liège
Liege, WAL, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Open Label Phase I/II Study to Determine the Safety and Immune Modulating Effects of the Therapeutic Human Papilloma Virus 16 (HPV16) E6/E7 Long Peptides Vaccine (ISA101/ISA101b) Immunotherapy in Combination With Standard of Care Therapy (Carboplatin and Paclitaxel With or Without Bevacizumab) in Women With HPV16 Positive Advanced or Recurrent Cervical Cancer Who Have no Curative Treatment Options
A Multicenter, Open Label Phase I/II Study to Determine the Safety and Immune Modulating Effects of the Therapeutic Human Papilloma Virus 16 (HPV16) E6/E7 Long Peptides Vaccine (ISA101/ISA101b) Immunotherapy in Combination With Standard of Care Therapy (Carboplatin and Paclitaxel With or Without Bevacizumab) in Women With HPV16 Positive Advanced or Recurrent Cervical Cancer Who Have no Curative Treatment Options
Enrollment Status: Completed
Publish Date: March 06, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

72 Total Publications

Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688].
Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688].
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 30, 2026

Frequently Asked Questions about Frederic Goffin

Is Frederic Goffin a top-rated expert for Gestational Trophoblastic Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Frederic Goffin is classified as an Elite expert for Gestational Trophoblastic Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Frederic Goffin participate in research or clinical trials?

Yes. Frederic Goffin has published 72 articles and abstracts on conditions like Gestational Trophoblastic Disease. You can view a list of Frederic Goffin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Goffin's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile